Novo Nordisk AS(NVO.US)

Event Tracking

Jan2

Novo Nordisk reportedly lowers the price of its weight-loss drug in the Chinese market

12:40

Novo Nordisk's GLP-1 drug semaglutide fails in Alzheimer's trial

06:00

Novo Nordisk Faces a 'Must-Win Battle' in the US Market to Revive Investor Confidence

05:30

Trump Administration Strikes Deal with Nine Major Pharmaceutical Companies to Cut Prices

00:00

Jan1

Novo Nordisk has announced its dividend plan for August 2026.

22:51

Novo Nordisk stock ex-dividend date

14:02

Schedules & Filings

Schedules

Filings

Feb4

Earning Release(EST)

FY2025 Annual Earning Release

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.78 B, Net Income 3.143 B, EPS 0.707

Novo Nordisk A/S (NVO.US) Q3 2025 Earnings Conference Call

Aug26

Distribution Plan(EST)

Cash dividend 0.5843 USD

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change